Thienopyridone derivatives as AMPactivated protein kinase (AMPK) activators

Details for Australian Patent Application No. 2009243811 (hide)

Owner Merck Patent GmbH

Inventors Cravo, Daniel; Charon, Christine; Hallakou-Bozec, Sophie; Lepifre, Franck

Agent Davies Collison Cave

Pub. Number AU-A-2009243811

PCT Pub. Number WO2009/135580

Priority 08290423.6 05.05.08 EP

Filing date 8 April 2009

Wipo publication date 12 November 2009

International Classifications

C07D 333/38 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

Event Publications

23 December 2010 PCT application entered the National Phase

  PCT publication WO2009/135580 Priority application(s): WO2009/135580

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009243812-NIP thiazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1

2009243805-Control channel signalling for triggering the independent transmission of a channel quality indicator